May 22, 2009 (Boston, Massachusetts) — In an unusually long follow-up of patients from one of cardiology's most influential trials, implantable cardioverter defibrillator (ICD) therapy in a ...

Orlando, FL - A new analysis of data from the Multicenter Automatic Defibrillator Implantation Trial (MADIT II) shows a benefit from ICD therapy in elderly patients with ischemic cardiomyopathy, with ...

MADIT-CRT is a significant continuation of Boston Scientific’s sponsorship of certain landmark clinical trials such as MADIT, MADIT II, and COMPANION. MADIT-CRT is the largest randomized NYHA Class ...

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial.

Women in the randomized MADIT-CRT trial had significantly greater reductions in death or HF, HF alone and all-cause mortality with cardiac resynchronization therapy using defibrillator than men.

Among patients with mild heart failure, only those who have left bundle branch block (LBBB) stand to gain better long-term survival from receiving cardiac resynchronization therapy (CRT) in addition ...

Barcelona, Spain, 1 September: Asymptomatic or mildly symptomatic cardiac patients randomised to an implanted cardiac resynchronisation device with defibrillator (CRT-D) have a 34% lower risk of heart ...

Short- and long-term risks of ventricular tachycardia or ventricular fibrillation, and of recurrent events, are related to the presence of transient or persistent physiological factors. Ventricular ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio WASHINGTON — Seven-year follow-up data of ...